U.S. Markets closed

CymaBay Therapeutics Stock Crashes Over 50%: Is It Viable?

Jitendra Parashar
CymaBay Therapeutics Stock Crashes Over 50%: Is It Viable?

June 11 turned out to be a terrible day for US biopharmaceutical company CymaBay Therapeutics’ (CBAY) investors.